ObRb downregulation increases breast cancer cell sensitivity to tamoxifen
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s13277-015-3375-5.pdf
Reference31 articles.
1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. Cancer J Clin. 2012;62(1):10–29. doi: 10.3322/caac.20138 .
2. Hurvitz SA, Pietras RJ. Rational management of endocrine resistance in breast cancer: a comprehensive review of estrogen receptor biology, treatment options, and future directions. Cancer. 2008;113(9):2385–97. doi: 10.1002/cncr.23875 .
3. Briest S, Stearns V. Tamoxifen metabolism and its effect on endocrine treatment of breast cancer. Clin Adv Hematol Oncol. 2009;7(3):185–92.
4. Lonning PE. Adjuvant endocrine treatment of early breast cancer. Hematol Oncol Clin North Am. 2007;21(2):223–38. doi: 10.1016/j.hoc.2007.03.002 .
5. Delozier T, Spielmann M, Mace-Lesec’h J, Janvier M, Hill C, Asselain B, et al. Tamoxifen adjuvant treatment duration in early breast cancer: initial results of a randomized study comparing short-term treatment with long-term treatment. Federation Nationale des Centres de Lutte Contre le Cancer Breast Group. J Clin Oncol. 2000;18(20):3507–12.
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring the multifaceted role of obesity in breast cancer progression;Frontiers in Cell and Developmental Biology;2024-07-08
2. Obesity and endocrine therapy resistance in breast cancer: Mechanistic insights and perspectives;Obesity Reviews;2021-09-24
3. Current Landscape: The Mechanism and Therapeutic Impact of Obesity for Breast Cancer;Frontiers in Oncology;2021-07-19
4. Roles and mechanisms of adipokines in drug resistance of tumor cells;European Journal of Pharmacology;2021-05
5. The Relationship between Leptin, the Leptin Receptor and FGFR1 in Primary Human Breast Tumors;Cells;2020-10-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3